催化后期多样化和抗增殖活性评估埃沃胺的催化后期多样化和抗增殖活性评估
Jing Wang1, Yang Yang1, Ming-Li Zhou1
1Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs, School of Life Science and Engineering, Southwest Jiaotong University Chengdu 610031 People's Republic of China gaof@swjtu.edu.cn xujinbu@swjtu.edu.cn liansun@swjtu.edu.cn.
RSC advances
|March 12, 2026
概括
研究人员合成了N-13-arylated埃沃胺衍生物来测试抗瘤活性. 直接关联显示细胞毒性较差,但插入药可能会增强这些evodiaamine类型的抗癌作用.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 埃沃胺是一种生物活性天然产品,具有潜在的抗癌特性.
- 修改天然产品是药物发现的关键策略.
- 晚期的多样化允许快速生成类似的产品.
研究的目的:
- 为了合成新的N-13-arylated埃沃胺衍生物.
- 评估这些衍生物的体外抗瘤活性.
- 探索结构-活性关系,以提高抗癌疗效.
主要方法:
- 铜催化C-N合器用于埃沃胺的晚期多样化.
- 一系列N-13-arylated的埃沃胺衍生物 (3a-3v) 的合成.
- 在实验室中对HCT-116,4T1和SU-DHL-6癌细胞系进行细胞毒性测定.
主要成果:
- 合成了22个N-13-化埃沃胺衍生物.
- 在N-13位置的直接结合导致不令人满意的细胞毒性.
- 初步的结构-活动关系分析表明了增强的潜力.
结论:
- 直接N-13对埃沃胺的化并不是增强细胞毒性的有效策略.
- 在N-13位置和基之间插入药片段可以改善抗瘤活性.
- 这些发现为开发更强效的基于埃沃胺的抗癌剂提供了洞察力.
相关概念视频
Inhibition of CDK Activity
5.6K
5.6K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K


